| Melissa Ann Elverud, RN | |
|
2800 Cleveland Ave N, Roseville, MN 55113-1126 | |
| (612) 642-1825 | |
| Not Available |
| Full Name | Melissa Ann Elverud |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 2800 Cleveland Ave N, Roseville, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013201821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R 197270-0 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Ann Elverud, RN 2800 Cleveland Ave N, Roseville, MN 55113-1126 Ph: (612) 642-1825 | Melissa Ann Elverud, RN 2800 Cleveland Ave N, Roseville, MN 55113-1126 Ph: (612) 642-1825 |
News Archive
Fibromyalgia, a disorder that causes pain, fatigue, chronic headaches and a host of other symptoms, is often misunderstood by patients, families and health care providers. A new book from Mayo Clinic Press aims to change that.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib, a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer.
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.
As President Obama readies his State of the Union address, the American Academy of Actuaries is urging policymakers to adopt four cornerstones to focus the nation's domestic policy agenda to improve the financial security of all Americans and restore the nation's fiscal health.
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the completion of an agreement with the Joslin Diabetes Center to exclusively license intellectual property covering bone morphogenetic protein 7 (BMP7), which has been shown to play a role in the regulation of brown fat development.
› Verified 3 days ago
Heidi M Osborn, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 | |
Melissa Lynne Schmidt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 | |
Heather Marie Semler, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 | |
Keather Luci Richards, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 | |
Mary Wendt, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 | |
Jean Stumpf, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 Cleveland Ave N, Roseville, MN 55113 Phone: 651-642-1825 |